HFA Premium Access

Panel discussion and close - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Topic: Comorbidities
Organised by MedEd Global Solutions & University of Lorraine, supported with an educational grant from Vifor Pharma

Congress Presentation

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)
114 presentations
15 followers

4 more presentations in this session

Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

Speaker: Professor M. Lainscak (Murska Sobota, SI)

Thumbnail

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.

Speaker: Professor I. Pina (Philadelphia, US)

Thumbnail

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The nephrologist’s perspective.

Speaker: Professor P. Rossignol (Monaco, MC)

Thumbnail

Access the full session

Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

Speakers: Professor J. Butler, Professor F. Zannad, Professor M. Lainscak, Professor I. Pina, Professor P. Rossignol
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb